Development Of A Novel Nutraceutical Product For The Adjuvant Treatment Of Inflammatory Bowel Disease
Programme
EUREKA
Technological Area
6.1.12-Pharmaceutical Products / Drugs
Start Date
01-Jan-2007
End date
01-Jan-2009
Duration(months)
24
Actual cost (MEuro)
0.28
Summary
To Develop A Novel Formulation Of Naturally Occurring Anti-Oxidant/ Anti-Inflammatory Compounds For The Management And Adjunctive Therapy Of Inflammatory Bowel Disease (IBD).
Budget and Duration
Phase
Budget (MEURO)
Duration (Months)
Definition phase
0.24
22
Implementation phase
0.04
2
Total
0.28
24
Member Contribution
Member
Contribution
Position
Cyprus
86.00 %
Contact Member
Greece
14.00 %
Participating Member
Participants
Company
Country
Type
Role
Yasoo Health Ltd.
Cyprus
SME
Main
University Of Cyprus
Cyprus
University
Partner
University Of Crete / Laboratory Of Experimental Endocrinology / School Of Medicine
